Recurrent Fsgs Foundation Inc

Nonprofit profile at a glance

EIN
332548549
IRS 990-EZ coverage
2024–2024
Forms available
Form 990-EZ 2024
Location
Detroit, MI, USA
Phone
3139631212
Rating confidence
Limited
Sector
Kidney Disease

Reported finances

Revenue
$0
Expenses
$0
Assets
$0
Liabilities
$0

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

4 people listed

Executive titles in this filing

  • DOV LOKETCH (PRESIDENT)
  • DOV LOKETCH (PRESIDENT)

People named in this filing

  • DOV LOKETCH (PRESIDENT)
  • DOV LOKETCH (PRESIDENT)
  • GARY TORGOW (TREASURER)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

The organization will work to improve patient outcomes and enhance the quality of life for those affected by recurrent focal segmentalglomerular sclerosis (rfsgs). Among the ways this may be done is through advancing research and development of effective treatments, collaborative partnerships with relevant professionals and organizations, patient support and education and advocacy leading to increasedawareness.

What it reported doing in 2024

Research and development of effective treatments for recurrent focal segmentalglomerular sclerosis (rfsgs.

Operating model

Revenue model
Cannot be determined from the filing. The filing does not provide enough consistent revenue detail to tell how this nonprofit funds its work.
Distribution model
No current program activity. The filing reports no program spending for the current year.

The verdict

- The available evidence is not sufficient to produce an overall rating for this filing. This is not a warning sign.

Rating breakdown

  • Financial Efficiency: NotEnoughData
  • Transparency & Controls: 41
  • Sustainability: NotEnoughData
  • Growth: NotEnoughData

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: Limited
  • Program expense ratio: Limited

Transparency & Controls

  • Consistency checks: 50%; rating input score 50; 0th percentile among comparable filings
  • Major donor itemization: Limited

Sustainability

  • Operating margin: Limited
  • Total-asset coverage ratio: Limited
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: Limited

Growth

  • Program expense growth: Limited
  • Revenue growth: Limited
  • Asset growth: Limited

Details

  • Where the money goes: Financial trends and filed revenue, expense, asset, and liability detail
  • Governance: Filed governance answers
  • Accomplishments: 1 filed program accomplishment
  • Leadership: top reported pay $0 · 4 people listed
  • Consistency: 5 of 6 current checks pass · 1 finding to review
  • Schedules: 1 filed schedules
  • Contacts: How to reach this organization
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Transparency & Controls: Series filing activity did not reconcile in the filed values.